192 related articles for article (PubMed ID: 29910047)
1. Design and rationale of the Fontan Udenafil Exercise Longitudinal (FUEL) trial.
Goldberg DJ; Zak V; Goldstein BH; McCrindle BW; Menon SC; Schumacher KR; Payne RM; Rhodes J; McHugh KE; Penny DJ; Trachtenberg F; Hamstra MS; Richmond ME; Frommelt PC; Files MD; Yeager JL; Pemberton VL; Stylianou MP; Pearson GD; Paridon SM;
Am Heart J; 2018 Jul; 201():1-8. PubMed ID: 29910047
[TBL] [Abstract][Full Text] [Related]
2. Results of the FUEL Trial.
Goldberg DJ; Zak V; Goldstein BH; Schumacher KR; Rhodes J; Penny DJ; Petit CJ; Ginde S; Menon SC; Kim SH; Kim GB; Nowlen TT; DiMaria MV; Frischhertz BP; Wagner JB; McHugh KE; McCrindle BW; Shillingford AJ; Sabati AA; Yetman AT; John AS; Richmond ME; Files MD; Payne RM; Mackie AS; Davis CK; Shahanavaz S; Hill KD; Garg R; Jacobs JP; Hamstra MS; Woyciechowski S; Rathge KA; McBride MG; Frommelt PC; Russell MW; Urbina EM; Yeager JL; Pemberton VL; Stylianou MP; Pearson GD; Paridon SM;
Circulation; 2020 Feb; 141(8):641-651. PubMed ID: 31736357
[TBL] [Abstract][Full Text] [Related]
3. Results of a phase I/II multi-center investigation of udenafil in adolescents after fontan palliation.
Goldberg DJ; Zak V; Goldstein BH; Chen S; Hamstra MS; Radojewski EA; Maunsell E; Mital S; Menon SC; Schumacher KR; Payne RM; Stylianou M; Kaltman JR; deVries TM; Yeager JL; Paridon SM;
Am Heart J; 2017 Jun; 188():42-52. PubMed ID: 28577680
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Udenafil on Heart Rate and Blood Pressure in Adolescents With the Fontan Circulation.
Edelson JB; Zak V; Goldberg D; Fleming G; Mackie AS; Patel JK; Files M; Downing T; Richmond M; Acheampong B; Cartoski M; Detterich J; McCrindle B; McHugh K; Hansen JE; Wagner J; Maria MD; Weingarten A; Nowlen T; Yoon JK; Kim GB; Williams R; Whitehill R; Kirkpatrick E; Yin S; Ermis P; Lubert AM; Stylianou M; Freemon D; Hu C; Garuba OD; Frommelt P; Goldstein BH; Paridon S; Garg R;
Am J Cardiol; 2024 Jan; 210():183-187. PubMed ID: 37918818
[TBL] [Abstract][Full Text] [Related]
5. The Fontan Udenafil Exercise Longitudinal Trial: Subgroup Analysis.
Goldberg DJ; Hu C; Lubert AM; Rathod RH; Penny DJ; Petit CJ; Schumacher KR; Ginde S; Williams RV; Yoon JK; Kim GB; Nowlen TT; DiMaria MV; Frischhertz BP; Wagner JB; McHugh KE; McCrindle BW; Cartoski MJ; Detterich JA; Yetman AT; John AS; Richmond ME; Yung D; Payne RM; Mackie AS; Davis CK; Shahanavaz S; Hill KD; Almaguer M; Zak V; McBride MG; Goldstein BH; Pearson GD; Paridon SM;
Pediatr Cardiol; 2023 Dec; 44(8):1691-1701. PubMed ID: 37382636
[TBL] [Abstract][Full Text] [Related]
6. PDE 5 inhibition with udenafil improves left ventricular systolic/diastolic functions and exercise capacity in patients with chronic heart failure with reduced ejection fraction; A 12-week, randomized, double-blind, placebo-controlled trial.
Kim KH; Kim HK; Hwang IC; Cho HJ; Je N; Kwon OM; Choi SJ; Lee SP; Kim YJ; Sohn DW
Am Heart J; 2015 Jun; 169(6):813-822.e3. PubMed ID: 26027619
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Udenafil for the Treatment of Pulmonary Arterial Hypertension: a Placebo-controlled, Double-blind, Phase IIb Clinical Trial.
Chang HJ; Song S; Chang SA; Kim HK; Jung HO; Choi JH; Lee JS; Kim KH; Jeong JO; Lee JH; Kim DK
Clin Ther; 2019 Aug; 41(8):1499-1507. PubMed ID: 31202506
[TBL] [Abstract][Full Text] [Related]
8. Impact of Udenafil on Echocardiographic Indices of Single Ventricle Size and Function in FUEL Study Participants.
Di Maria MV; Goldberg DJ; Zak V; Hu C; Lubert AM; Dragulescu A; Mackie AS; McCrary A; Weingarten A; Parthiban A; Goot B; Goldstein BH; Taylor C; Lindblade C; Petit CJ; Spurney C; Harrild DM; Urbina EM; Schuchardt E; Beom Kim G; Kyoung Yoon J; Colombo JN; Files MD; Schoessling M; Ermis P; Wong PC; Garg R; Swanson SK; Menon SC; Srivastava S; Thorsson T; Johnson TR; Krishnan US; Paridon SM; Frommelt PC;
Circ Cardiovasc Imaging; 2022 Nov; 15(11):e013676. PubMed ID: 36378780
[TBL] [Abstract][Full Text] [Related]
9. Commentary: Fontan circulation, pulmonary blood flow, and lessons from the FUEL (Fontan Udenafil Exercise Longitudinal) study.
Karamichalis JM
J Thorac Cardiovasc Surg; 2021 Oct; 162(4):1239-1240. PubMed ID: 33451847
[No Abstract] [Full Text] [Related]
10. Efficacy and tolerability of udenafil in Turkish men with erectile dysfunction of psychogenic and organic aetiology: a randomized, double-blind, placebo-controlled study.
Ortaç M; Çayan S; Çalişkan MK; Yaman MÖ; Okutucu TM; Semerci MB; Altay AB; Balbay MD; Özcan MF; Kadioğlu A
Andrology; 2013 Jul; 1(4):549-55. PubMed ID: 23785019
[TBL] [Abstract][Full Text] [Related]
11. Impact of bosentan on exercise capacity in adults after the Fontan procedure: a randomized controlled trial.
Schuuring MJ; Vis JC; van Dijk AP; van Melle JP; Vliegen HW; Pieper PG; Sieswerda GT; de Bruin-Bon RH; Mulder BJ; Bouma BJ
Eur J Heart Fail; 2013 Jun; 15(6):690-8. PubMed ID: 23361871
[TBL] [Abstract][Full Text] [Related]
12. Design and rationale of re-energize fontan: Randomized exercise intervention designed to maximize fitness in fontan patients.
Selamet Tierney ES; Palaniappan L; Leonard M; Long J; Myers J; Dávila T; Lui MC; Kogan F; Olson I; Punn R; Desai M; Schneider LM; Wang CH; Cooke JP; Bernstein D
Am Heart J; 2023 May; 259():68-78. PubMed ID: 36796574
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of udenafil for erectile dysfunction: a meta-analysis of randomized controlled trials.
Ding H; Du W; Wang H; Zhang L; Wang Z; Du C; Tao Y
Urology; 2012 Jul; 80(1):134-9. PubMed ID: 22497982
[TBL] [Abstract][Full Text] [Related]
14. Effect of Tadalafil on Myocardial and Endothelial Function and Exercise Performance After Modified Fontan Operation.
Sabri MR; Zolfi-Gol A; Ahmadi A; Haghjooy-Javanmard S
Pediatr Cardiol; 2016 Jan; 37(1):55-61. PubMed ID: 26215768
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary vasodilator therapy in the failing Fontan circulation: rationale and efficacy.
Snarr BS; Paridon SM; Rychik J; Goldberg DJ
Cardiol Young; 2015 Dec; 25(8):1489-92. PubMed ID: 26675595
[TBL] [Abstract][Full Text] [Related]
16. A therapeutic confirmatory study to assess the safety and efficacy of Zydena (udenafil) for the treatment of erectile dysfunction in male patients with diabetes mellitus.
Moon du G; Yang DY; Lee CH; Ahn TY; Min KS; Park K; Park JK; Kim JJ
J Sex Med; 2011 Jul; 8(7):2048-61. PubMed ID: 21554549
[TBL] [Abstract][Full Text] [Related]
17. Understanding of chest pain in microvascular disease proved by cardiac magnetic resonance image (UMPIRE): study protocol for a randomized controlled trial.
Park SJ; Park JJ; Choi DJ; Chun EJ; Choi SI; Kim SM; Jang SY; Ahn S; Choe YH
Trials; 2014 Aug; 15():333. PubMed ID: 25154607
[TBL] [Abstract][Full Text] [Related]
18. Drug therapy in the prevention of failure of the Fontan circulation: a systematic review.
Oldenburger NJ; Mank A; Etnel J; Takkenberg JJ; Helbing WA
Cardiol Young; 2016 Jun; 26(5):842-50. PubMed ID: 26947621
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of udenafil for the treatment of erectile dysfunction after total mesorectal excision of rectal cancer: a randomized, double-blind, placebo-controlled trial.
Park SY; Choi GS; Park JS; Kim HJ; Park JA; Choi JI
Surgery; 2015 Jan; 157(1):64-71. PubMed ID: 25482466
[TBL] [Abstract][Full Text] [Related]
20. Head-to-head comparison of udenafil vs amlodipine in the treatment of secondary Raynaud's phenomenon: a double-blind, randomized, cross-over study.
Lee EY; Park JK; Lee W; Kim YK; Park CS; Giles JT; Park JW; Shin K; Lee JS; Song YW; Lee EB
Rheumatology (Oxford); 2014 Apr; 53(4):658-64. PubMed ID: 24352340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
